Briefing
IMpower010: chemotherapy cleared postoperative ctDNA in 62% of patients who had it, and clearance tracked with longer DFS
The ESMO 2024 IMpower010 ctDNA update reported that chemotherapy converted 62% of patients who were ctDNA-positive after surgery to ctDNA-negative, and that this clearance was associated with longer disease-free survival.